MedPath

Comparison of two medications used to increase blood pressure i.e. phenylephrine and norepinephrine for treatment of fall in bloodpressure during caesarean delivery under spinal anaesthesia in patients with babies in compromised situatio

Phase 4
Completed
Conditions
Health Condition 1: O469- Antepartum hemorrhage, unspecifiedHealth Condition 2: O68- Labor and delivery complicated byabnormality of fetal acid-base balanceHealth Condition 3: O410- Oligohydramnios
Registration Number
CTRI/2018/12/016518
Lead Sponsor
niversity College of Medical Sciences and Guru Teg Bahadur Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1. Healthy females with singleton pregnancy undergoing emergency caesarean section for potential fetal compromise under spinal anaesthesia

2. Non-reassuring fetal heart rate (FHR) status i.e. FHR more than 160 or less than 100 bpm

3. FHR deceleration(variable or late), which fails to recover after uterine contraction has passed (type 2 dips)

4. Meconium stained liquor with FHR abnormality or thick meconium stained liquor

5. Cord prolapse

6. Intra-uterine growth restriction

7. Oligohydramnios

8. Antepartum haemorrhage

9. Dystocia

10. Postmaturity

11. Prematurity

Exclusion Criteria

1. Maternal complications e.g. pre-eclampsia, cardiovascular disease, cerebrovascular disease

2. Multiple gestation

3. Known fetal abnormality

4. Patients with absolute or relative contra-indications for spinal anaesthesia e.g. infection in lumbar area, coagulation abnormalities, autonomic neuropathy, spinal deformities, other neurological diseases, hypovolemia due to any cause

5. Maternal baseline SBP less than 100 mmHg

6. Severely compromised fetus requiring immediate administration of general anaesthesia to mother

7. Patients on monoamine oxidase inhibitors or tricyclic antidepressants

8. History suggestive of mesenteric or peripheral vascular thrombosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢ Umbilical artery pHTimepoint: â?¢Time of delivery of baby
Secondary Outcome Measures
NameTimeMethod
â?¢ APGAR scores at 1 and 5 minutes <br/ ><br>â?¢ Incidence of fetal acidosis, defined as umbilical artery pH less than 7.20 <br/ ><br>â?¢ Number of neonates requiring admission to neonatal intensive care unit with their duration of stay <br/ ><br>â?¢ Total dose of vasopressor given <br/ ><br>â?¢ Number of episodes of hypotension <br/ ><br>â?¢ Incidence of bradycardia/ tachycardia/ arrhythmias <br/ ><br>â?¢ Incidence of nausea, vomiting, dizziness or any other complications <br/ ><br>Timepoint: Till the time of delivery of baby
© Copyright 2025. All Rights Reserved by MedPath